← Leaderboards
David S Strayer
Thomas Jefferson University
$8,559,654
Attributed
$8,559,654
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–08$2M$1.5M$1M$500K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$11,857,788 · 10
By mechanism
R01$5,729,630 · 4
P01$3,298,134 · 3
U01$2,277,524 · 1
R21$552,500 · 2
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Rocky S. Tuan$6,072,688
Others in their field
Top investigators on “Transfection /Expression Vector”
- William W Hauswirth · University Of Florida$14,472,513
- Kenneth G Cornetta · Indiana Univ-Purdue Univ At Indianapolis$10,466,261
- Klaus H. Kaestner · University Of Pennsylvania$8,467,407
- David T Curiel · University Of Alabama At Birmingham$8,321,535
- Timothy A Cross · Florida State University$7,979,166
- John H Wolfe · Children'S Hospital Of Philadelphia$7,103,743
Research focus
Transfection /Expression VectorSimian Virus 40Gene TherapyAids TherapyHiv InfectionsHuman Immunodeficiency Virus 1Tissue /Cell CultureLaboratory MouseGene Delivery SystemVirus ReplicationSimian Immunodeficiency VirusMacrophageApoptosisMethod DevelopmentHuman SubjectClinical ResearchTechnology /Technique DevelopmentAntibodyHiv Envelope Protein Gp120TransfectionScid MouseImmunizationAids VaccinesAids Education /Prevention
Grant awards (32)
Targeting HIV infection of the cns using gene delivery$372,161
R01 · FY2008 · MH · contact PI
FOCUSING IMMUNITY vs BOTULINUM TOXIN WITH CYTOKINE DNA$500,438
U01 · FY2007 · AI · contact PI
Targeting HIV infection of the cns using gene delivery$372,161
R01 · FY2007 · MH · contact PI
FOCUSING IMMUNITY vs BOTULINUM TOXIN WITH CYTOKINE DNA$503,289
U01 · FY2006 · AI · contact PI
Targeting HIV infection of the cns using gene delivery$383,276
R01 · FY2006 · MH · contact PI
SFV GENE DELIVERY TO INHIBIT HIV AND SIV INTEGRASE$530,952
R01 · FY2005 · AI
FOCUSING IMMUNITY vs BOTULINUM TOXIN WITH CYTOKINE DNA$503,372
U01 · FY2005 · AI
Targeting HIV infection of the cns using gene delivery$392,500
R01 · FY2005 · MH
SFV GENE DELIVERY TO INHIBIT HIV AND SIV INTEGRASE$518,486
R01 · FY2004 · AI
FOCUSING IMMUNITY vs BOTULINUM TOXIN WITH CYTOKINE DNA$499,475
U01 · FY2004 · AI
Targeting HIV infection of the cns using gene delivery$392,500
R01 · FY2004 · MH
PROTECTING CNS CELLS FROM HIV AND HIV-INDUCED INJURY$157,000
R21 · FY2004 · MH
SV40-BASED COMBINATION GENETIC THERAPIES FOR HIV/SIV$865,618
P01 · FY2003 · AI
SFV GENE DELIVERY TO INHIBIT HIV AND SIV INTEGRASE$504,472
R01 · FY2003 · AI
FOCUSING IMMUNITY vs BOTULINUM TOXIN WITH CYTOKINE DNA$270,950
U01 · FY2003 · AI
PROTECTING CNS CELLS FROM HIV AND HIV-INDUCED INJURY$157,000
R21 · FY2003 · MH
SV40-BASED COMBINATION GENETIC THERAPIES FOR HIV/SIV$792,796
P01 · FY2002 · AI
SFV GENE DELIVERY TO INHIBIT HIV AND SIV INTEGRASE$436,130
R01 · FY2002 · AI
Use of SV40 derived vectors to inhibit HIV 1 infection$0
P01 · FY2002 · AI
Core--Vector facility$0
P01 · FY2002 · AI
SV40-BASED COMBINATION GENETIC THERAPIES FOR HIV/SIV$814,838
P01 · FY2001 · AI
SFV GENE DELIVERY TO INHIBIT HIV AND SIV INTEGRASE$492,957
R01 · FY2001 · AI
ANIMAL MODELS OF AIDS--POLYTAR INHIBITION OF SIV$434,799
R01 · FY2001 · RR
PATHOGENESIS OF MALIGNANT FIBROMATOSIS$239,917
R01 · FY2001 · CA
Core--Vector facility$0
P01 · FY2001 · AI
Use of SV40 derived vectors to inhibit HIV 1 infection$0
P01 · FY2001 · AI
SV40-BASED COMBINATION GENETIC THERAPIES FOR HIV/SIV$824,882
P01 · FY2000 · AI
ANIMAL MODELS OF AIDS--POLYTAR INHIBITION OF SIV$429,277
R01 · FY2000 · RR
IMMUNIZATION AGAINST LENTIVIRAL GP120 USING SV40 VECTORS$238,500
R21 · FY2000 · AI
PATHOGENESIS OF MALIGNANT FIBROMATOSIS$230,042
R01 · FY2000 · CA
Core--Vector facility$0
P01 · FY2000 · AI
Use of SV40 derived vectors to inhibit HIV 1 infection$0
P01 · FY2000 · AI